Related Experiment Video
Updated: Jul 13, 2026

06:58
Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
Context of use matters: interpreting extracellular vesicle TDP-43 as a biomarker in ALS
1Institute of Medical Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UK. jenna.gregory@abdn.ac.uk.
Acta Neuropathologica Communications
|July 11, 2026
Abstract
No abstract available in PubMed .
Keywords:
Amyotrophic lateral sclerosisBiomarkersClinical trialsNeuron-derived extracellular vesiclesNeuropathologyPharmacodynamic biomarkersSurrogate endpointsTDP-43More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015